Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3828c2b2-c91a-4585-9339-eb718499fd48&Preview=1
Date 7/24/2012
Company Name Histogenics
Mailing Address 830 Winter Street 3rd Floor Waltham, MA 02451
Company Description Histogenics is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair. Its cartilage regeneration products apply advanced cell biology, tissue engineering, and materials science in the repair of injured or diseased joints, to restore joint function and prevent degenerative disease.
Proceeds Purposes Proceeds will be used to complete the ongoing Phase 3 clinical program for lead product candidate NeoCart, which is currently enrolling patients. NeoCart is an autologous neocartilage tissue implant that utilizes the patient’s own cells to regenerate cartilage in patients suffering from cartilage lesions in the knee. Funds will also support efforts to obtain regulatory clearance in the European Union for product candidate VeriCart, a single-step, cell-free collagen scaffold uniquely designed to be used in conjunction with the patient’s own stem cells, to repair small cartilage defects frequently observed in meniscal and anterior cruciate ligament repair procedures.
